GL1X · GenesisL1 explorer

Research workbench

CRYSTAL STRUCTURE OF PfKRS WITH INHIBITOR CLADO-2

Analyse CRYSTAL STRUCTURE OF PfKRS WITH INHIBITOR CLADO-2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5ZH5
Type
protein
Length
953 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
3.08
Source
Plasmodium falciparum NF54
Molecule
Lysine--tRNA ligase
EC
6.1.1.6
UniProt
W7JP72
Ligands
LYS, 9CX, CL
Pockets
12 · best druggability 0.85

Structure

x-ray diffraction · resolution 3.08 · 2 distinct chains · 32% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysine--tRNA ligase (EC 6.1.1.6)protein48231% helix, 26% strandW7JP72
BLysine--tRNA ligase (EC 6.1.1.6)protein47133% helix, 25% strandW7JP72

Ligands and binding sites

  • LYS · Lysine · ligand · 2 copies · chains A, B
  • 9CX · (3S)-6,8-dihydroxy-3-{[(2R,6S)-6-methyloxan-2-yl]methyl}-3,4-dihydro-1H-2-benzopyran-1-one · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12480.850.9654empty
29720.790.8196LYS, 9CX
39970.760.78100LYS, 9CX
41330.580.8428empty
51710.580.8231empty

Interfaces

1 interface between chains.

  • A–B · 4342 Ų buried · 55 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5ZH5 · Crystal structure of pfkrs with inhibitor clado-2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.